{"id":1016159,"date":"2026-11-02T12:36:03","date_gmt":"2026-11-02T17:36:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/"},"modified":"2026-11-02T12:36:03","modified_gmt":"2026-11-02T17:36:03","slug":"disc-medicine-to-participate-in-upcoming-investor-conferences-8","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/","title":{"rendered":"Disc Medicine to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">WATERTOWN, Mass., Nov.  02, 2026  (GLOBE NEWSWIRE) &#8212; Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that company management will participate in fireside chats at upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">Guggenheim 3<sup>rd<\/sup> Annual Healthcare Innovation Conference on Monday, November 9<sup>th<\/sup> at 10:30 a.m. ET\n<\/li>\n<li style=\"margin-bottom:8pt\">Stifel 2026 Healthcare Conference on Thursday, November 12<sup>th<\/sup> at 2:00 p.m. ET\n<\/li>\n<li style=\"margin-bottom:8pt\">UBS Global Biopharma Conference on Tuesday, November 17<sup>th<\/sup> at 3:40 a.m. ET \/ 8:40 a.m. GMT\n<\/li>\n<li style=\"margin-bottom:8pt\">Jefferies London Global Healthcare Conference on Wednesday, November 18<sup>th<\/sup> at 6:30 a.m. ET \/ 11:30 a.m. GMT\n<\/li>\n<\/ul>\n<p align=\"justify\">Disc management will be participating in investor meetings during the above conferences, as well as during the Truist BioPharma Symposium in New York on Thursday, November 12.<\/p>\n<p align=\"justify\">Live webcasts of the fireside chats will be available through the investor relations section of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=us77-XlpAWe6Bgz-TbrReafHv7PW6wqz5OmIMOdep5s6D_o0jYmJB3qqR0d8kY7qn4WVuOOyS-VgNOr9MSezuopvQmX46n9W0orgHy4DDEo=\" rel=\"nofollow\" target=\"_blank\">ir.discmedicine.com<\/a> and an archived replay will be available after each event.<\/p>\n<p align=\"justify\">\n        <strong>About Disc Medicine<\/strong>\n      <\/p>\n<p align=\"justify\">Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E3sekBYhrDIoaaW0N0bRwApvYS2EYTyyY0soyge8DICE3ED3H01Qv-vSZqxKNghQAfjhF0iF0eY9hRhxiuPcvzXXr878iPmBxIp1MQYgFcU=\" rel=\"nofollow\" target=\"_blank\">www.discmedicine.com<\/a>.<\/p>\n<p>\n        <strong>Media Contact<\/strong>\n      <\/p>\n<p>Peg Rusconi<br \/>Deerfield Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3d172kXupVS2XxydaAQMUMf6DUcL0CAgo0Q3vxL-eloN9FHQss4Xdd7Vfg0Z1-pJ0_YCQjLRAkqZTEmNz-9CBhtsKw_DeBqet20TyG4LOK_hqqmeWbmol5LRfTOatDnG\" rel=\"nofollow\" target=\"_blank\">peg.rusconi@deerfieldgroup.com<\/a><\/p>\n<p>\n        <strong>Investor Relations Contact<\/strong>\n      <\/p>\n<p>Kevin Lui<br \/>Precision AQ <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LiwOKmEkU4Pn1v0fJqqTpftkIUKV8KyLbysBwtRpgweceuwm_5eXckRIn5KROwIDJ1QkVEbR9vqbgIExPmngJigxM5bfZisZDeNXEvCy_XLNZbNTsDBIim7N22E0X320\" rel=\"nofollow\" target=\"_blank\">kevin.lui@precisionaq.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzQwMCM3OTI3ODExIzIyMjQ3NzM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZGI0MDUyNmEtMjU0My00NDFiLWI4NDEtY2RiMWJhYWQ5MTJiLTEyMzYzMjYtMjAyNi0xMS0wMi1lbg==\/tiny\/Disc-Medicine-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that company management will participate in fireside chats at upcoming investor conferences: Guggenheim 3rd Annual Healthcare Innovation Conference on Monday, November 9th at 10:30 a.m. ET Stifel 2026 Healthcare Conference on Thursday, November 12th at 2:00 p.m. ET UBS Global Biopharma Conference on Tuesday, November 17th at 3:40 a.m. ET \/ 8:40 a.m. GMT Jefferies London Global Healthcare Conference on Wednesday, November 18th at 6:30 a.m. ET \/ 11:30 a.m. GMT Disc management will be participating in investor meetings during the above conferences, as well &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Disc Medicine to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1016159","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Disc Medicine to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Disc Medicine to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that company management will participate in fireside chats at upcoming investor conferences: Guggenheim 3rd Annual Healthcare Innovation Conference on Monday, November 9th at 10:30 a.m. ET Stifel 2026 Healthcare Conference on Thursday, November 12th at 2:00 p.m. ET UBS Global Biopharma Conference on Tuesday, November 17th at 3:40 a.m. ET \/ 8:40 a.m. GMT Jefferies London Global Healthcare Conference on Wednesday, November 18th at 6:30 a.m. ET \/ 11:30 a.m. GMT Disc management will be participating in investor meetings during the above conferences, as well &hellip; Continue reading &quot;Disc Medicine to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-02T17:36:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzQwMCM3OTI3ODExIzIyMjQ3NzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Disc Medicine to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-11-02T17:36:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\\\/\"},\"wordCount\":261,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NzQwMCM3OTI3ODExIzIyMjQ3NzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\\\/\",\"name\":\"Disc Medicine to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NzQwMCM3OTI3ODExIzIyMjQ3NzM=\",\"datePublished\":\"2026-11-02T17:36:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NzQwMCM3OTI3ODExIzIyMjQ3NzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NzQwMCM3OTI3ODExIzIyMjQ3NzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Disc Medicine to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Disc Medicine to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/","og_locale":"en_US","og_type":"article","og_title":"Disc Medicine to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"WATERTOWN, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that company management will participate in fireside chats at upcoming investor conferences: Guggenheim 3rd Annual Healthcare Innovation Conference on Monday, November 9th at 10:30 a.m. ET Stifel 2026 Healthcare Conference on Thursday, November 12th at 2:00 p.m. ET UBS Global Biopharma Conference on Tuesday, November 17th at 3:40 a.m. ET \/ 8:40 a.m. GMT Jefferies London Global Healthcare Conference on Wednesday, November 18th at 6:30 a.m. ET \/ 11:30 a.m. GMT Disc management will be participating in investor meetings during the above conferences, as well &hellip; Continue reading \"Disc Medicine to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-02T17:36:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzQwMCM3OTI3ODExIzIyMjQ3NzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Disc Medicine to Participate in Upcoming Investor Conferences","datePublished":"2026-11-02T17:36:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/"},"wordCount":261,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzQwMCM3OTI3ODExIzIyMjQ3NzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/","name":"Disc Medicine to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzQwMCM3OTI3ODExIzIyMjQ3NzM=","datePublished":"2026-11-02T17:36:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzQwMCM3OTI3ODExIzIyMjQ3NzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NzQwMCM3OTI3ODExIzIyMjQ3NzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/disc-medicine-to-participate-in-upcoming-investor-conferences-8\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Disc Medicine to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016159","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1016159"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016159\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1016159"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1016159"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1016159"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}